Search details
1.
Targeting the fibroblast growth factor pathway in molecular subtypes of castration-resistant prostate cancer.
Prostate
; 84(1): 100-110, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37796107
2.
Hypothesis: evidence that the PRS gene products of Saccharomyces cerevisiae support both PRPP synthesis and maintenance of cell wall integrity.
Curr Genet
; 70(1): 6, 2024 May 11.
Article
in English
| MEDLINE | ID: mdl-38733432
3.
Evaluation of initial prostate cancer biopsies utilizing 3D open-top light-sheet microscopy for detection of early disease.
Prostate
; 83(11): 1121-1124, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37165548
4.
Clinical, pathologic, and molecular features of amphicrine prostate cancer.
Prostate
; 83(7): 641-648, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36779357
5.
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Cancer Immunol Immunother
; 72(3): 775-782, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-35998004
6.
Pathological Effects of Apalutamide in Lower-risk Prostate Cancer: Results From a Phase II Clinical Trial.
J Urol
; 209(2): 354-363, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36621991
7.
Mismatch repair deficiency and clinical implications in prostate cancer.
Prostate
; 82 Suppl 1: S37-S44, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35358351
8.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate
; 81(16): 1382-1389, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34516663
9.
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer.
Prostate
; 81(7): 418-426, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33755225
10.
Clinical determinants for successful circulating tumor DNA analysis in prostate cancer.
Prostate
; 79(7): 701-708, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30865311
11.
The NHR1-1 of Prs1 and the pentameric motif 284KKCPK288 of Prs3 permit multi-functionality of the PRPP synthetase in Saccharomyces cerevisiae.
FEMS Yeast Res
; 19(2)2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30649305
12.
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.
Lancet Oncol
; 19(1): 76-86, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29248236
13.
Reply by Authors.
J Urol
; 209(2): 362-363, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36621992
14.
Prognostic and therapeutic implications of DNA repair gene mutations in advanced prostate cancer.
Clin Adv Hematol Oncol
; 15(10): 785-795, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-29040258
15.
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.
Prostate
; 76(14): 1303-11, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27324988
16.
Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.
Prostate
; 76(13): 1218-26, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27338150
17.
Metabolic gene products have evolved to interact with the cell wall integrity pathway in Saccharomyces cerevisiae.
FEMS Yeast Res
; 16(8)2016 12.
Article
in English
| MEDLINE | ID: mdl-27744273
18.
Immunotherapy for prostate cancer: recent developments and future challenges.
Cancer Metastasis Rev
; 33(2-3): 641-55, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24477411
19.
Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.
Prostate
; 75(15): 1814-20, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26306637
20.
Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.
Prostate
; 74(13): 1278-85, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-25053178